Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 3/2020

01-03-2020 | Original Article

Assessment of VITEK® MS IVD database V3.0 for identification of Nocardia spp. using two culture media and comparing direct smear and protein extraction procedures

Authors: T. Durand, F. Vautrin, E. Bergeron, V. Girard, S. Polsinelli, V. Monnin, G. Durand, O. Dauwalder, O. Dumitrescu, F. Laurent, V. Rodríguez-Nava

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 3/2020

Login to get access

Abstract

We assessed the performance of the VITEK® MS IVD V3.0 matrix-assisted laser desorption ionization - time of flight mass spectrometry (MALDI-ToF MS) V3.0 database for the identification of Nocardia spp. as compared with targeted DNA sequencing. A collection of 222 DNA sequence-defined Nocardia spp. strains encompassing 18 different species present or not in the database was tested. Bromocresol purple agar (BCP) and Columbia agar +5% sheep’s blood (COS) culture media were used together with two different preparation steps: direct smear and a “3 attempts” procedure that covered (1) spotting of an extract, (2) new spotting of the same extract, and (3) spotting of a new extract. The direct smear protocol yielded low correct identification rates (≤ 15% for both media) whereas protein extraction yielded correct identification results (> 67% regardless of the media used.). The use of 2 additional attempts using repeat or new extracts increased correct identification rates to 87% and 91% for BCP and COS, respectively. When using the 3 attempts procedure, the best identification results, independent of media types, were obtained for N. farcinica and N. cyriacigeorgica (100%). Identification attempts 2 and 3 allowed to increase the number of correct identifications (BCP, +20%; COS, +13%). The enhancement in performance during attempts 2 and 3 was remarkable for N. abscessus (81% for both media) and low prevalence species (BCP, 70%; COS, 85%). Up to 3.4% and 2.4% of the strains belonging to species present in the database were misidentified with BCP and COS media, respectively. In 1.9% of the cases for BCP and 1.4% for COS, these misidentifications concerned a species belonging to the same phylogenetic complex. Concerning strains that are not claimed in the V3.0 database, N. puris and N. goodfellowi generated “No identification” results and 100% of the strains belonging to N. arthritidis, N. cerradoensis, and N. altamirensis yielded a misidentification within the same phylogenetic complex. Vitek® MS IVD V3.0 is an accurate and useful tool for identification of Nocardia spp.
Literature
13.
go back to reference Buckwalter SP, Olson SL, Connelly BJ, Lucas BC, Rodning AA, Walchak RC, Deml SM, Wohlfiel SL, Wengenack NL (2016) Evaluation of matrix-assisted laser desorption ionization−time of flight mass spectrometry for identification of mycobacterium species, Nocardia species, and other aerobic actinomycetes. J Clin Microbiol 54:376–384. https://doi.org/10.1128/JCM.02128-15CrossRefPubMedPubMedCentral Buckwalter SP, Olson SL, Connelly BJ, Lucas BC, Rodning AA, Walchak RC, Deml SM, Wohlfiel SL, Wengenack NL (2016) Evaluation of matrix-assisted laser desorption ionization−time of flight mass spectrometry for identification of mycobacterium species, Nocardia species, and other aerobic actinomycetes. J Clin Microbiol 54:376–384. https://​doi.​org/​10.​1128/​JCM.​02128-15CrossRefPubMedPubMedCentral
16.
go back to reference Girard V, Mailler S, Welker M, Arsac M, Cellière B, Cotte-Pattat P-J, Chatellier S, Durand G, Béni AM, Schrenzel J, Miller E, Dussoulier R, Dunne WM Jr, Butler-Wu S, Saubolle MA, Sussland D, Bell M, van Belkum A, Deol P (2016) Identification of Mycobacterium spp. and Nocardia spp. from solid and liquid cultures by matrix-assisted laser desorption ionization–time of flight mass spectrometry (MALDI-TOF MS). Diagn Microbiol Infect Dis 86:277–283. https://doi.org/10.1016/j.diagmicrobio.2016.07.027CrossRefPubMed Girard V, Mailler S, Welker M, Arsac M, Cellière B, Cotte-Pattat P-J, Chatellier S, Durand G, Béni AM, Schrenzel J, Miller E, Dussoulier R, Dunne WM Jr, Butler-Wu S, Saubolle MA, Sussland D, Bell M, van Belkum A, Deol P (2016) Identification of Mycobacterium spp. and Nocardia spp. from solid and liquid cultures by matrix-assisted laser desorption ionization–time of flight mass spectrometry (MALDI-TOF MS). Diagn Microbiol Infect Dis 86:277–283. https://​doi.​org/​10.​1016/​j.​diagmicrobio.​2016.​07.​027CrossRefPubMed
18.
go back to reference Body BA, Beard MA, Slechta ES, Hanson KE, Barker AP, Babady NE, McMillen T, Tang YW, Brown-Elliott BA, Iakhiaeva E, Vasireddy R, Vasireddy S, Smith T, Wallace RJ Jr, Turner S, Curtis L, Butler-Wu S, Rychert J (2018) Evaluation of the Vitek MS v3.0 matrix-assisted laser desorption ionization–time of flight mass spectrometry system for identification of Mycobacterium and Nocardia species. J Clin Microbiol. https://doi.org/10.1128/JCM.00237-18 Body BA, Beard MA, Slechta ES, Hanson KE, Barker AP, Babady NE, McMillen T, Tang YW, Brown-Elliott BA, Iakhiaeva E, Vasireddy R, Vasireddy S, Smith T, Wallace RJ Jr, Turner S, Curtis L, Butler-Wu S, Rychert J (2018) Evaluation of the Vitek MS v3.0 matrix-assisted laser desorption ionization–time of flight mass spectrometry system for identification of Mycobacterium and Nocardia species. J Clin Microbiol. https://​doi.​org/​10.​1128/​JCM.​00237-18
20.
go back to reference Rodriguez-Nava V, Couble A, Devulder G, Flandrois J-P, Boiron P, Laurent F (2006) Use of PCR-restriction enzyme pattern analysis and sequencing database for hsp65 gene-based identification of Nocardia species. J Clin Microbiol 44:536–546CrossRef Rodriguez-Nava V, Couble A, Devulder G, Flandrois J-P, Boiron P, Laurent F (2006) Use of PCR-restriction enzyme pattern analysis and sequencing database for hsp65 gene-based identification of Nocardia species. J Clin Microbiol 44:536–546CrossRef
21.
go back to reference CLSI (2008) MM18-A: interpretive criteria for identification of bacteria and fungi by DNA target sequencing, 1st edn. CLSI, Wayne CLSI (2008) MM18-A: interpretive criteria for identification of bacteria and fungi by DNA target sequencing, 1st edn. CLSI, Wayne
26.
go back to reference Tamura T, Ohji S, Ichikawa N, Hosoyama A, Yamazoe A, Hamada M et al (2018) Reclassification of Nocardia species based on whole genome sequence and associated phenotypic data. J Antibiot (Tokyo) 71:633–641CrossRef Tamura T, Ohji S, Ichikawa N, Hosoyama A, Yamazoe A, Hamada M et al (2018) Reclassification of Nocardia species based on whole genome sequence and associated phenotypic data. J Antibiot (Tokyo) 71:633–641CrossRef
27.
go back to reference Gilquin JM, Riviere B, Jurado V, Audouy B, Kouatche JB, Bergeron E, Mouniée D, Molina T, Faure P, Saiz-Jimenez C, Rodríguez-Nava V (2016) First case of actinomycetoma in France due to a novel Nocardia species, Nocardia boironii sp. nov. mSphere 1(6). https://doi.org/10.1128/mSphere.00309-16 Gilquin JM, Riviere B, Jurado V, Audouy B, Kouatche JB, Bergeron E, Mouniée D, Molina T, Faure P, Saiz-Jimenez C, Rodríguez-Nava V (2016) First case of actinomycetoma in France due to a novel Nocardia species, Nocardia boironii sp. nov. mSphere 1(6). https://​doi.​org/​10.​1128/​mSphere.​00309-16
Metadata
Title
Assessment of VITEK® MS IVD database V3.0 for identification of Nocardia spp. using two culture media and comparing direct smear and protein extraction procedures
Authors
T. Durand
F. Vautrin
E. Bergeron
V. Girard
S. Polsinelli
V. Monnin
G. Durand
O. Dauwalder
O. Dumitrescu
F. Laurent
V. Rodríguez-Nava
Publication date
01-03-2020
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 3/2020
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-019-03758-x

Other articles of this Issue 3/2020

European Journal of Clinical Microbiology & Infectious Diseases 3/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.